PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

abiraterone vs ethinyl estradiol/norethindrone

Side-by-side comparison of abiraterone and ethinyl estradiol/norethindrone Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
abiraterone CYP17 Inhibitor
ethinyl estradiol/norethindrone Combined Oral Contraceptive
Type
abiraterone Prescription
ethinyl estradiol/norethindrone Prescription
Summary
abiraterone

Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread. It works by lowering the amount of androgen your body makes.

ethinyl estradiol/norethindrone

Lo Loestrin Fe is a birth control pill. It helps prevent pregnancy in women.

What It Treats
abiraterone

Abiraterone is used to treat prostate cancer that has spread to other parts of the body. It is for cancers that are castration-resistant, meaning they no longer respond to hormone therapy alone. It is also used for high-risk castration-sensitive prostate cancer. You will take this medicine with prednisone.

ethinyl estradiol/norethindrone

Lo Loestrin Fe is used to prevent pregnancy. It contains two hormones, a progestin and an estrogen. It works by preventing the release of an egg from your ovary.

How It Works
abiraterone

Abiraterone blocks an enzyme called CYP17, which your body needs to make androgens. Androgens can help prostate cancer grow. By blocking this enzyme, abiraterone lowers androgen levels and slows cancer growth.

ethinyl estradiol/norethindrone

Lo Loestrin Fe contains two hormones: norethindrone acetate and ethinyl estradiol. These hormones prevent ovulation (the release of an egg from the ovary). They also change the lining of the uterus, making it harder for a fertilized egg to implant.

Common Side Effects
abiraterone
  • Feeling tired
  • Joint pain
  • High blood pressure
  • Feeling sick to your stomach
  • Swelling
ethinyl estradiol/norethindrone
  • Nausea or vomiting
  • Headache
  • Irregular bleeding
  • Painful periods
  • Weight changes
FAERS Reports
abiraterone
  • Death 1,390
  • Feeling tired 1,022
  • Hot flash 678
  • Weakness 562
  • Worsening of disease 561
ethinyl estradiol/norethindrone

No adverse event reports.

Serious Warnings
abiraterone

Abiraterone can cause problems with mineralocorticoid excess, like high blood pressure, low potassium, and fluid retention. If you have heart problems, your doctor will monitor you closely. This medicine can also cause liver problems, which can be severe. Your doctor will check your liver function regularly. Do not take abiraterone with radium Ra 223 dichloride. Abiraterone can harm an unborn baby, so men should use effective birth control if their partner can get pregnant.

ethinyl estradiol/norethindrone

Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke. Women over 35 who smoke should not use Lo Loestrin Fe.

Pregnancy
abiraterone

Abiraterone can cause harm to an unborn baby. Men who are taking abiraterone should use effective birth control during treatment and for 3 weeks after the last dose if their partner is able to get pregnant. It is not known if abiraterone passes into breast milk.

ethinyl estradiol/norethindrone

Do not use Lo Loestrin Fe if you are pregnant. It can also reduce milk production while breastfeeding, so other birth control options are recommended.

Also Compare — Nearby Drugs

How to Read This abiraterone vs ethinyl estradiol/norethindrone Comparison

abiraterone is classified in the CYP17 Inhibitor drug class, while ethinyl estradiol/norethindrone sits within the Combined Oral Contraceptive class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abiraterone has 4,213 submissions while ethinyl estradiol/norethindrone has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abiraterone and ethinyl estradiol/norethindrone — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.